A-Alpha Bio

The protein-protein interaction company.

Seattle, United States · Founded 2017 · $46.9M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$46.9M
Last Round
$22.4M Series AJul 2023
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

A-Alpha Bio is a Seattle-based biotechnology company using its AlphaSeq and AlphaBind platforms to generate and analyze billions of protein-protein interaction data points. By combining high-throughput synthetic biology experiments with machine learning, A-Alpha Bio accelerates antibody discovery, targeted protein degradation, and the development of high-impact medicines for cancer, infectious disease, and more.

Summary

A-Alpha Bio is an Artificial Intelligence company based in Seattle, United States, founded in 2017. It has raised $46.9M in total across 6 rounds, most recently a $22.4M Series A round in Jul 2023. Investors include Perceptive Xontogeny Ventures, Madrona Venture and Bill & Melinda Gates Foundation.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A2Jul 2023
$22.4M

Sign up to see all 6 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

A-Alpha Bio on Indexed.vc
<a href="https://indexed.vc/companies/a-alpha-bio"><img src="https://indexed.vc/api/badge/company/a-alpha-bio" alt="A-Alpha Bio on Indexed.vc" width="260" height="76" /></a>